AsPC-1 Orthotopic Model


AsPC-1 is a well-established human pancreatic adenocarcinoma cell line used as a model for studying pancreatic cancer. It retains characteristics of pancreatic adenocarcinoma, including epithelial morphology, invasiveness, and expression of tumor markers. AsPC-1 is commonly employed in pancreatic cancer research to investigate disease mechanisms, evaluate therapeutic responses, and test novel treatment approaches. This cell line aids in understanding pancreatic cancer biology and the development of improved strategies for patient management.

Model Details

Cancer Type: Pancreatic Cancer
Model Name: AsPC-1
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Gemcitabine, Abraxane)

AsPC-1 Survival

Survival of AsPC-1 after orthotopic intrapancreatic injection of Nu/Nu mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content